Financial statements Specdrog

Balance sheet of Specdrog

Company age:
Age:
8 y. 6 m. 27 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of SPECDROG

Year
2018
2019
2020
2021
2023
Total assets 40 172,92 203 253,59 783 885,30 1 012 973,07 3 097 855,13
A. Fixed assets - - 174 703,34 386 554,28 806 520,23
B. Current assets 40 172,92 203 253,59 609 181,96 626 418,79 2 291 334,90
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 40 172,92 203 253,59 783 885,30 1 012 973,07 3 097 855,13
A. Equity 34 887,42 202 023,59 560 544,89 782 638,63 2 371 880,85
B. Liabilities and provisions for liabilities 5 285,50 1 230,00 223 340,41 230 334,44 725 974,28
I. Long-term liabilities - - - - -
II. Short-term liabilities - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.